CTRI/2009/091/000208已完成3 期
Maxi-Analgesic Junior Study:A multi-centre prospective, parallel group, double-blind, randomized comparison of the analgesic effect of a combination of paracetamol and ibuprofen with paracetamol alone or ibuprofen alone in post tonsillectomy patients
AFT Pharmaceuticals New Zealand0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Present to study centre for routine tonsillectomy, under the care of a participating surgeon.
- •Be between 6-14 years of age on the day of consent.
- •Provide written informed consent before initiation of any study-related procedures from a parent or legal guardian and, where appropriate, written assent themselves.
- •We acknowledge that some children are able to provide consent, but will not recruit any subject unless both the patient and his or her parent or legal guardian are willing for this to occur and the parent or legal guardian must still provide his/her own consent.
排除标准
- •Patients will be excluded from the study if any of the following exclusion criteria apply prior to randomization:
- •Study contra-indications
- •?Patient declines assent (or consent) or parent declines consent.
- •?Too young (<6 years) or too old (>14 years).
- •?Too small (weight below 15kg at base line visit).
- •?Having taken any NSAID or paracetamol within 12 hours prior to the operation.
- •?Known to be pregnant or possibly pregnant.
- •?Suffering from a neurological disorder relating to pain perception.
- •?In the opinion of the study staff, unable to understand the visual analogue pain score.
- •?Currently or in last 30 days, having participated in a clinical trial involving another study drug.
- •?Suffering from any other diseases or condition which, in the opinion of the investigator, means that it would not be in the patient?s best interests to participate in this study.
- •NSAID and/or paracetamol contra-indications
- •?Hypersensitivity to aspirin or other NSAID.
- •?Hypersensitivity to paracetamol.
- •?Severe known haemopoetic, renal or hepatic disease, immunosuppressant.
- •?History of gastric ulceration, indigestion, stomach pain or bleeding.
- •?Currently suffering from dehydration through diarrhoea and/or vomiting.
- •?History of severe asthma defined as previous steroid treatment or hospital admission.
研究者
相似试验
已完成
3 期
Maxi-Analgesic StudyACTRN12606000291583AFT Pharmaceuticals120
撤回
3 期
Maxi-Analgesic Osteoarthritis (OA) StudyOsteoarthritisNCT01420666AFT Pharmaceuticals, Ltd.
已完成
2 期
A clinical trial to study the effects of Maxigesic (paracetamol 500mg + ibuprofen 150 mg) with the other 3 treatment groups (paracetamol 500 mg; low dose ibuprofen 150 mg; high dose ibuprofen 300mg) in patients who have painful osteoarthritis of the knee.CTRI/2009/091/000096AFT Pharmaceuticals32
进行中(未招募)
1 期
A MULTICENTRE CLINICAL TRIAL EVALUATING THE ANALGESIC EFFICACY AND SAFETY OF DEXKETOPROFEN TROMETAMOL (50 mg i.v. FOLLOWED BY AN ORAL DOSAGE OF 25 mg t.i.d.) VERSUS METAMIZOL (2 g i.v. and 575 mg t.i.d. BY ORAL ROUTE) FOR THE TREATMENT OF PAIN SUBSEQUENT TO AMBULATORY MAJOR SURGERYEUCTR2004-001789-42-ESaboratorios Menarini, S.A.160
已完成
不适用
Multi-Centre Trial to Evaluate the Clinical Performance of the Lifetech/Medtronic Ceraflex-ASD-Occluder for Transcatheter Closure of Secundum Atrial Septal DefectsAtrial septal defectQ21.1DRKS00010233Deutsches Herzzentrum München149
